The options were granted in accordance with Nasdaq Listing Rule 5635(4).
The options have an exercise price of
About
Contact:
Tel: (201) 705-0254
Email: jarrod.aldom@kalvista.com
(C) 2023 Electronic News Publishing, source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.3 USD | +2.31% |
|
+24.51% | +24.82% |
12/07 | Needham Adjusts Price Target on KalVista Pharmaceuticals to $32 From $35, Maintains Buy Rating | MT |
11/07 | KalVista Pharmaceuticals Files $300 Million Mixed Shelf | MT |
The options were granted in accordance with Nasdaq Listing Rule 5635(4).
The options have an exercise price of
About
Contact:
Tel: (201) 705-0254
Email: jarrod.aldom@kalvista.com
(C) 2023 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+24.82% | 639M | |
+7.40% | 101B | |
+8.42% | 42.18B | |
-13.34% | 32.26B | |
+80.80% | 29.79B | |
-11.32% | 16.06B | |
+2.17% | 14.45B | |
-6.77% | 12.01B | |
+177.16% | 10.71B | |
+4.12% | 8.89B |